Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S3AE
|
|||
| Former ID |
DIB011579
|
|||
| Drug Name |
Anti-MUC1 AR20.5 mab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 1 | [1] | |
| Company |
Quest pharmatech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity. Ann Oncol. 2004 Dec;15(12):1825-33. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.